Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis

Slides:



Advertisements
Similar presentations
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Advertisements

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
Zhumin Zhang, Suzanne M. Shoff, HuiChuan J. Lai 
Sweat conductivity: An accurate diagnostic test for cystic fibrosis?
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis  H.J.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis  Paul M. Beringer, Levita Hidayat, Anna Heed, Ling.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut,
Early attained weight and length predict growth faltering better than velocity measures in infants with CF  Sonya L. Heltshe, Drucy S. Borowitz, Daniel.
Cirrhosis and other liver disease in cystic fibrosis
John Widger, Sarath Ranganathan, Philip J. Robinson 
The ease of breathing test tracks clinical changes in cystic fibrosis
Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection  Charles R. Esther, Rongpong Plongla, Alan Kerr, Feng-Chang Lin,
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Cynthia M. Ward, Tara Brinkman, Keith J. Slifer, Shruti M. Paranjape 
Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state  Bradley.
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients  Filip Van Ginderdeuren, Karlien Van Cauwelaert,
Vitamin A and lung function in CF
Thomas Radtke, Milo A. Puhan, Helge Hebestreit, Susi Kriemler 
Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous ΔF508 controls  Jonathan McCormick, Simon A. Ogston,
Pulmonary nocardiosis in cystic fibrosis
An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis  Patrick John Lenehan, Craig M. Schramm, Melanie.
A.H. Gifford  Journal of Cystic Fibrosis 
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Tregony Simoneau, Gregory S. Sawicki, Carly E. Milliren, Henry A
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Physiologic endpoints for clinical studies for cystic fibrosis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan,
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Ruth H. Keogh, Sanja Stanojevic  Journal of Cystic Fibrosis 
Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage  Luke J. Berry, Barbara Sheil, Luke Garratt,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate.
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
Beta-lactam allergy in adults with cystic fibrosis
Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States  Kathleen J. Ramos, Bradley S. Quon, Kevin.
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
Treatment intensity and characteristics of MRSA infection in CF
Michael W. Konstan, Jeffrey S. Wagener, Donald R. VanDevanter, David J
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Absence of a gender gap in survival
Cystic fibrosis and pregnancy in the modern era: A case control study
Presentation transcript:

Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis Katharina Ruf, Helge Hebestreit  Journal of Cystic Fibrosis  Volume 8, Issue 2, Pages 83-90 (March 2009) DOI: 10.1016/j.jcf.2008.09.008 Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Relationship between (A) SpO2 at rest and SpO2 at peak exercise, (B) between FEV1 and SpO2 at peak exercise, and (C) between 1/FEV1 and SpO2 at peak exercise. Journal of Cystic Fibrosis 2009 8, 83-90DOI: (10.1016/j.jcf.2008.09.008) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Performance of a formula to predict peak exercise SpO2 using SpO2 at rest and 1/FEV1 as independent predictors. A) Relationship between predicted SpO2 at peak exercise and observed SpO2 at peak exercise. The continuous line indicates the line of identity, the dashed lines a SpO2 of 90%. The numbers in the four quadrants of the graph represent the number of patients with the respective SpO2 values above or below 90%. B) Bland-Altman plot of residual SpO2 at peak exercise (SpO2measured–SpO2predicted) over SpO2 at peak exercise predicted using SpO2 at rest plus 1/FEV1 as predictors. The continuous line indicates the mean residual, the dashed lines the 95%-confidence interval. Journal of Cystic Fibrosis 2009 8, 83-90DOI: (10.1016/j.jcf.2008.09.008) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 ECG recordings obtained at rest and at peak exercise from two patients with CF. Both patients developed severe exercise-triggered ventricular arrhythmia. A) Female patient, 18-years-old, FEV1: 22.3% predicted, SpO2 at rest: 92%, SpO2 at peak exercise: 74%. B) Male patient, 40-years-old, FEV1:23,2% predicted, SpO2 at rest: 95%, SpO2 at peak exercise:86%. Journal of Cystic Fibrosis 2009 8, 83-90DOI: (10.1016/j.jcf.2008.09.008) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions